Biocentis
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$6.91M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biocentis operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in November 2025.
Biocentis is a biotechnology company that develops next-generation genetic technologies and AI-driven solutions for sustainable insect control to protect public health, agriculture, and biodiversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocentis Comparables
Compare Biocentis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synvect | 81% | |
| MosquitoMate, Inc. | 79% | |
| Agragene Inc | 79% |
For institutional investors. Book with your work email.
Biocentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Nov 27, 2023 | ||||
| Grant | Oct 14, 2023 | ||||
| Pre Seed | Feb 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biocentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neurone | Grant, Pre Seed |
| Corbites | Grant |
| The Grantham Foundation for the Protection of the Environment | Grant |
| Jeremy and Hannelore Grantham Environmental Trust | Grant |
| Italian Ministry of University and Research | Grant |
| Novaterra | Grant |
| Algebris Investments | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$19M raised in Seed round.
- Oct 14, 2023
$445K grant round completed.
For institutional investors. Book with your work email.
Biocentis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biocentis's valuation, stock price, and market status.
Is Biocentis a public or private company?
Biocentis is a private company.
What is the current stock price of Biocentis?
Biocentis is a private company, so its shares have no public market price. Caplight tracks Biocentis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biocentis worth (valuation)?
Valuation information for Biocentis is not publicly available.
Can I buy Biocentis stock?
Biocentis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biocentis's last funding round?
Biocentis's most recent funding round was Grant on November 19, 2025.
Who are the main investors in Biocentis?
Key investors in Biocentis include The Grantham Foundation for the Protection of the Environment, Algebris Investments.
Will Biocentis IPO soon?
No public IPO plans have been announced for Biocentis.
How can I track Biocentis secondary market activity?
Caplight tracks bids, offers, and trades in Biocentis's shares on secondary markets.